4/22
02:12 pm
glpg
Galapagos NV (NASDAQ: GLPG) had its "equal weight" rating re-affirmed by analysts at Morgan Stanley. They now have a $38.00 price target on the stock.
Low
Report
Galapagos NV (NASDAQ: GLPG) had its "equal weight" rating re-affirmed by analysts at Morgan Stanley. They now have a $38.00 price target on the stock.
4/4
04:04 pm
glpg
Galapagos showcases innovative approach in hematological cancer care with clinical and translational data presentations at EBMT congress 2024 [Yahoo! Finance]
Neutral
Report
Galapagos showcases innovative approach in hematological cancer care with clinical and translational data presentations at EBMT congress 2024 [Yahoo! Finance]
4/4
04:01 pm
glpg
Galapagos showcases innovative approach in hematological cancer care with clinical and translational data presentations at EBMT congress 2024
Neutral
Report
Galapagos showcases innovative approach in hematological cancer care with clinical and translational data presentations at EBMT congress 2024
3/28
04:19 pm
glpg
Galapagos publishes 2023 annual report and announces Annual and Extraordinary Shareholders' Meetings [Yahoo! Finance]
Low
Report
Galapagos publishes 2023 annual report and announces Annual and Extraordinary Shareholders' Meetings [Yahoo! Finance]
3/28
04:01 pm
glpg
Galapagos publishes 2023 annual report and announces Annual and Extraordinary Shareholders’ Meetings
Low
Report
Galapagos publishes 2023 annual report and announces Annual and Extraordinary Shareholders’ Meetings
3/28
08:07 am
glpg
Galapagos NV (NASDAQ: GLPG) had its "underperform" rating re-affirmed by analysts at Bank of America Co.. They now have a $31.00 price target on the stock, down previously from $41.00.
Low
Report
Galapagos NV (NASDAQ: GLPG) had its "underperform" rating re-affirmed by analysts at Bank of America Co.. They now have a $31.00 price target on the stock, down previously from $41.00.
3/26
04:01 pm
glpg
Galapagos appoints Andrew Dickinson as Non-Executive Non-Independent Director to its Board
Low
Report
Galapagos appoints Andrew Dickinson as Non-Executive Non-Independent Director to its Board
3/18
11:06 pm
glpg
Galapagos NV (NASDAQ: GLPG) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
Low
Report
Galapagos NV (NASDAQ: GLPG) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
3/18
10:47 am
glpg
Down -14.35% in 4 Weeks, Here's Why Galapagos NV (GLPG) Looks Ripe for a Turnaround [Yahoo! Finance]
Low
Report
Down -14.35% in 4 Weeks, Here's Why Galapagos NV (GLPG) Looks Ripe for a Turnaround [Yahoo! Finance]
3/7
08:02 am
glpg
Galapagos NV (NASDAQ: GLPG) had its "equal weight" rating re-affirmed by analysts at Morgan Stanley. They now have a $38.00 price target on the stock.
Low
Report
Galapagos NV (NASDAQ: GLPG) had its "equal weight" rating re-affirmed by analysts at Morgan Stanley. They now have a $38.00 price target on the stock.
3/2
02:02 am
glpg
Galapagos NV (NASDAQ: GLPG) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Medium
Report
Galapagos NV (NASDAQ: GLPG) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
2/24
08:38 am
glpg
Galapagos NV (NASDAQ:GLPG) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
Low
Report
Galapagos NV (NASDAQ:GLPG) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
2/23
11:06 pm
glpg
Galapagos NV (NASDAQ: GLPG) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
Low
Report
Galapagos NV (NASDAQ: GLPG) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
2/22
04:11 pm
glpg
Frontier Medicines Announces Oversubscribed $80 Million Series C Financing to Support Progress of Clinical-Stage Pipeline [Yahoo! Finance]
Medium
Report
Frontier Medicines Announces Oversubscribed $80 Million Series C Financing to Support Progress of Clinical-Stage Pipeline [Yahoo! Finance]
2/22
04:11 pm
glpg
Galapagos announces full year 2023 results and outlook for 2024 [Yahoo! Finance]
Medium
Report
Galapagos announces full year 2023 results and outlook for 2024 [Yahoo! Finance]
2/22
04:01 pm
glpg
Galapagos announces full year 2023 results and outlook for 2024
Medium
Report
Galapagos announces full year 2023 results and outlook for 2024
2/22
04:01 pm
glpg
Frontier Medicines Announces Oversubscribed $80 Million Series C Financing to Support Progress of Clinical-Stage Pipeline
Medium
Report
Frontier Medicines Announces Oversubscribed $80 Million Series C Financing to Support Progress of Clinical-Stage Pipeline
2/15
04:14 pm
glpg
Galapagos presents at EBMT-EHA annual meeting 2024 [Yahoo! Finance]
Low
Report
Galapagos presents at EBMT-EHA annual meeting 2024 [Yahoo! Finance]
2/15
04:01 pm
glpg
Galapagos presents at EBMT-EHA annual meeting 2024
Low
Report
Galapagos presents at EBMT-EHA annual meeting 2024
2/5
10:03 pm
glpg
Galapagos NV (NASDAQ: GLPG) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Low
Report
Galapagos NV (NASDAQ: GLPG) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
2/5
07:08 am
glpg
NodThera Announces Appointment of Dr. Thomas Jaecklin as Chief Medical Officer [Yahoo! Finance]
Low
Report
NodThera Announces Appointment of Dr. Thomas Jaecklin as Chief Medical Officer [Yahoo! Finance]
1/31
04:01 pm
glpg
Galapagos completes transaction to transfer Jyseleca® business to Alfasigma
Low
Report
Galapagos completes transaction to transfer Jyseleca® business to Alfasigma